Kasan Insight :: Korea IP Law Blog

Korea IP Law and Practice on Patent, Design, Trademark, Copyright, Trade Secrets and Unfair Competition

Remicade v. Remsima - Trademark Dispute between J&J and Celltrion

Remicade is a monoclonal antibody to treat RA. This blockbuster biopharmaceutical product was developed and has been sold by Centocor that ...

Statistics on New IP Applications Filed to KIPO in 2013

KIPO published the annual report of 2013 that includes statistics of filing numbers. In 2013, KIPO received 204,589 new patent applicat...

Reverse Payment Agreement violates Antitrust Law in Korea: the First case decision by the Korean Supreme Court for GSK v. KFTC case on Feb. 27, 2014

1. Background GSK owned a Korean patent for ondansetron, antiemetic drug and sold with a tradename as Zofran. Dong-A Pharmaceutical ...

Patent Marketing Approval Linkage

The FTA between Korea and USA includes provisions regarding the patent drug market approval (MA) linkage. Pursuant to the KORUS FTA, Korea h...

Benefits on Prior Art Search to Korean Language Documents in ICT Fields

Korea becomes one of the largest pools of patent publications in the world. In every year, KIPO receives over 350,000 domestic patent appli...

View web version

Powered by Blogger.